Screener
MoonLake Immunotherapeutics MLTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.34B.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
FAQ
- What is MoonLake Immunotherapeutics's market capitalization?
- MoonLake Immunotherapeutics (MLTX) reported market capitalization of $1.34B in Q1 2026.
- How has MoonLake Immunotherapeutics's market capitalization changed year-over-year?
- MoonLake Immunotherapeutics's market capitalization decreased by 45.9% year-over-year, from $2.47B to $1.34B.
- What is the long-term trend for MoonLake Immunotherapeutics's market capitalization?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's market capitalization has grown at a 26.5% compound annual growth rate (CAGR), from $365.19M to $933.77M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about MoonLake Immunotherapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude